PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease
JCI Insight · 2023
DOI: 10.1172/jci.insight.166107 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2023. Verfasst von Dhruti P Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel H…. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antibodies, Antineutrophil Cytoplasmic, Myeloblastin. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIDDK.
Abstract (Originalsprache)
A GWAS of patients with anti-neutrophil cytoplasmic antibodies (ANCAs) found an association between proteinase-3 ANCA (PR3-ANCA) and a single nucleotide polymorphism (rs62132293) upstream of PRTN3 , encoding PR3. The variant (G allele) was shown to be an expression quantitative trait locus in healthy controls, but the clinical impact remains unknown. Longitudinally followed patients with ANCA and healthy controls were genotyped. Gene expression was quantified by real-time quantitative PCR from leukocyte RNA. Plasma PR3 was quantified by ELISA. Among patients, variant carriers had elevated leukocyte PRTN3 expression compared with noncarriers (C/G vs. C/C and G/G vs. C/C). Healthy controls had low PRTN3 regardless of genotype. Myeloperoxidase ( MPO ) expression did not differ by genotype. PRTN3 expression correlated with circulating PR3, and variant carriers had higher plasma PR3 compared with noncarriers. Among variant carriers, there was an increased risk of relapse in patients with PR3-ANCA versus MPO-ANCA. The risk allele marked by rs62132293 is clinically significant as it is associated with increased autoantigen and may, in part, explain increased relapse in PR3-ANCA. Our results underscore the role of autoantigen availability in ANCA vasculitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Division of Pediatric Allergy, Immunology, and Rheumatology, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Pathology and Laboratory Medicine, and.
- Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Förderung
- NIDDK NIH HHS
- NIDDK
Zitieren
APA
Chen, D. P., Aiello, C. P., McCoy, D., Stamey, T., Yang, J., Hogan, S. L., Hu, Y., Derebail, V. K., Wu, E. Y., Jennette, J. C., Falk, R. J., & Ciavatta, D. J. (2023). PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease. JCI Insight. https://doi.org/10.1172/jci.insight.166107
Vancouver
Chen DP, Aiello CP, McCoy D, Stamey T, Yang J, Hogan SL, et al. PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease. JCI Insight. 2023. doi:10.1172/jci.insight.166107
BibTeX
@article{Chen2023,
author = {Chen, Dhruti P and Aiello, Claudia P and McCoy, DeMoris and Stamey, Taylor and Yang, Jiajin and Hogan, Susan L and Hu, Yichun and Derebail, Vimal K and Wu, Eveline Y and Jennette, J Charles and Falk, Ronald J and Ciavatta, Dominic J},
title = {PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease},
journal = {JCI Insight},
year = {2023},
doi = {10.1172/jci.insight.166107}
}
EUVIMED